Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19

Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-1...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2021/11/15, Vol.60(22), pp.3559-3567
Hauptverfasser: Ishiyama, Hiroyuki, Ishii, Junko, Yoshimura, Hajime, Tsunogae, Marie, Fujiwara, Satoru, Hiya, Satomi, Inui, Ryoma, Shiomi, Yuma, Nakazawa, Shinsaku, Kimura, Masamune, Kuroda, Takehito, Murakami, Yasutaka, Maekawa, Kota, Ohara, Nobuyuki, Kohara, Nobuo, Kawamoto, Michi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 3567
container_issue 22
container_start_page 3559
container_title Internal Medicine
container_volume 60
creator Ishiyama, Hiroyuki
Ishii, Junko
Yoshimura, Hajime
Tsunogae, Marie
Fujiwara, Satoru
Hiya, Satomi
Inui, Ryoma
Shiomi, Yuma
Nakazawa, Shinsaku
Kimura, Masamune
Kuroda, Takehito
Murakami, Yasutaka
Maekawa, Kota
Ohara, Nobuyuki
Kohara, Nobuo
Kawamoto, Michi
description Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-19 between March 1 and May 13, 2020. Acute neurological presentations (within two weeks of the symptom onset of COVID-19) were compared between 60 non-severe and 35 severely infected patients who required high-flow oxygen. In the 12 ventilated patients (the most severe group), we evaluated neurological complications during admission, subacute neurological presentations, and neurological sequelae (51 and 137 days from the onset [median], respectively). Results Of the 95 patients (mean age 53 years old; 40% women), 63% had acute neurological presentations, with an increased prevalence in cases of severe infections (83% vs. 52%, p
doi_str_mv 10.2169/internalmedicine.7802-21
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8666216</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2605315180</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-26fd5c467a6fc2aa588fe422829186e30e5c73f116864e47ecdd8fa273079eec3</originalsourceid><addsrcrecordid>eNplkcmOEzEQhi0EYsLAKyBLXLj04KXtdl-QUFhmpECQWCROlnFXJ44cO9huEDw9biVEMFyqDvXVX8uPEKbkilHZP3OhQArG72Fw1gW46hRhDaN30ILytm86xsVdtCA9VQ2r4QI9yHlHCFddz-6jC94KSoWUC_TlHUwp-rhx1nj81gQ3Qi6muBgyNmHAqxg2TZ22xx_g2wTeAHYBX8d8cMV49wsG_L7iEErGP1zZ4uX6883LhvYP0b3R-AyPTvkSfXr96uPyulmt39wsX6waKykpDZPjIGwrOyNHy4wRSo3QMqbmvSVwAsJ2fKRUKtlC24EdBjUa1nHS9QCWX6LnR93D9LX-w9ZNkvH6kNzepJ86Gqf_rQS31Zv4XSspZf1mFXh6EkixXpiL3rtswXsTIE5ZM9ExRtsaK_rkFrqL02xEpSQRnAqqSKXUkbIp5pxgPC9DiZ7907f907N_tVRbH_99zLnxj2EVWB-BXXVpA2fApOKsh_-VZR3J5ngacSbt1iQNgf8GqQG54A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605315180</pqid></control><display><type>article</type><title>Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19</title><source>MEDLINE</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Ishiyama, Hiroyuki ; Ishii, Junko ; Yoshimura, Hajime ; Tsunogae, Marie ; Fujiwara, Satoru ; Hiya, Satomi ; Inui, Ryoma ; Shiomi, Yuma ; Nakazawa, Shinsaku ; Kimura, Masamune ; Kuroda, Takehito ; Murakami, Yasutaka ; Maekawa, Kota ; Ohara, Nobuyuki ; Kohara, Nobuo ; Kawamoto, Michi</creator><creatorcontrib>Ishiyama, Hiroyuki ; Ishii, Junko ; Yoshimura, Hajime ; Tsunogae, Marie ; Fujiwara, Satoru ; Hiya, Satomi ; Inui, Ryoma ; Shiomi, Yuma ; Nakazawa, Shinsaku ; Kimura, Masamune ; Kuroda, Takehito ; Murakami, Yasutaka ; Maekawa, Kota ; Ohara, Nobuyuki ; Kohara, Nobuo ; Kawamoto, Michi</creatorcontrib><description>Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-19 between March 1 and May 13, 2020. Acute neurological presentations (within two weeks of the symptom onset of COVID-19) were compared between 60 non-severe and 35 severely infected patients who required high-flow oxygen. In the 12 ventilated patients (the most severe group), we evaluated neurological complications during admission, subacute neurological presentations, and neurological sequelae (51 and 137 days from the onset [median], respectively). Results Of the 95 patients (mean age 53 years old; 40% women), 63% had acute neurological presentations, with an increased prevalence in cases of severe infections (83% vs. 52%, p&lt;0.001). Impaired consciousness and limb weakness were more frequent in severe patients than in non-severe ones (0% vs. 49%; p&lt;0.001, and 0% vs. 54%; p&lt;0.001, respectively). In the most severe group (mean age 72 years old; 42% women), 83% of patients had neurological complications [cerebrovascular disease (17%), encephalopathy (82%), and neuropathy (55%)], and 92% had subacute neurological presentations [impaired consciousness (17%), higher brain dysfunction (82%), limb weakness (75%), and tremor (58%)]. Neurological sequelae were found in 83% of cases, including higher brain dysfunction (73%), limb weakness (50%), and tremor (58%). Conclusions Neurological manifestations are common in COVID-19, with the possibility of long-lasting sequelae.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.7802-21</identifier><identifier>PMID: 34511566</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Aged ; Cerebrovascular diseases ; Consciousness ; Coronaviruses ; COVID-19 ; Encephalopathy ; Female ; Hospitalization ; Humans ; infectious diseases ; intensive and critical care ; Internal medicine ; Male ; Middle Aged ; Nervous System Diseases - epidemiology ; Nervous System Diseases - etiology ; Neurological complications ; neurology ; Neuropathy ; Original ; Retrospective Studies ; SARS-CoV-2 ; Tremor</subject><ispartof>Internal Medicine, 2021/11/15, Vol.60(22), pp.3559-3567</ispartof><rights>2021 by The Japanese Society of Internal Medicine</rights><rights>Copyright Japan Science and Technology Agency 2021</rights><rights>Copyright © 2021 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-26fd5c467a6fc2aa588fe422829186e30e5c73f116864e47ecdd8fa273079eec3</citedby><cites>FETCH-LOGICAL-c610t-26fd5c467a6fc2aa588fe422829186e30e5c73f116864e47ecdd8fa273079eec3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666216/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666216/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,881,1877,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34511566$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ishiyama, Hiroyuki</creatorcontrib><creatorcontrib>Ishii, Junko</creatorcontrib><creatorcontrib>Yoshimura, Hajime</creatorcontrib><creatorcontrib>Tsunogae, Marie</creatorcontrib><creatorcontrib>Fujiwara, Satoru</creatorcontrib><creatorcontrib>Hiya, Satomi</creatorcontrib><creatorcontrib>Inui, Ryoma</creatorcontrib><creatorcontrib>Shiomi, Yuma</creatorcontrib><creatorcontrib>Nakazawa, Shinsaku</creatorcontrib><creatorcontrib>Kimura, Masamune</creatorcontrib><creatorcontrib>Kuroda, Takehito</creatorcontrib><creatorcontrib>Murakami, Yasutaka</creatorcontrib><creatorcontrib>Maekawa, Kota</creatorcontrib><creatorcontrib>Ohara, Nobuyuki</creatorcontrib><creatorcontrib>Kohara, Nobuo</creatorcontrib><creatorcontrib>Kawamoto, Michi</creatorcontrib><title>Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-19 between March 1 and May 13, 2020. Acute neurological presentations (within two weeks of the symptom onset of COVID-19) were compared between 60 non-severe and 35 severely infected patients who required high-flow oxygen. In the 12 ventilated patients (the most severe group), we evaluated neurological complications during admission, subacute neurological presentations, and neurological sequelae (51 and 137 days from the onset [median], respectively). Results Of the 95 patients (mean age 53 years old; 40% women), 63% had acute neurological presentations, with an increased prevalence in cases of severe infections (83% vs. 52%, p&lt;0.001). Impaired consciousness and limb weakness were more frequent in severe patients than in non-severe ones (0% vs. 49%; p&lt;0.001, and 0% vs. 54%; p&lt;0.001, respectively). In the most severe group (mean age 72 years old; 42% women), 83% of patients had neurological complications [cerebrovascular disease (17%), encephalopathy (82%), and neuropathy (55%)], and 92% had subacute neurological presentations [impaired consciousness (17%), higher brain dysfunction (82%), limb weakness (75%), and tremor (58%)]. Neurological sequelae were found in 83% of cases, including higher brain dysfunction (73%), limb weakness (50%), and tremor (58%). Conclusions Neurological manifestations are common in COVID-19, with the possibility of long-lasting sequelae.</description><subject>Aged</subject><subject>Cerebrovascular diseases</subject><subject>Consciousness</subject><subject>Coronaviruses</subject><subject>COVID-19</subject><subject>Encephalopathy</subject><subject>Female</subject><subject>Hospitalization</subject><subject>Humans</subject><subject>infectious diseases</subject><subject>intensive and critical care</subject><subject>Internal medicine</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Nervous System Diseases - epidemiology</subject><subject>Nervous System Diseases - etiology</subject><subject>Neurological complications</subject><subject>neurology</subject><subject>Neuropathy</subject><subject>Original</subject><subject>Retrospective Studies</subject><subject>SARS-CoV-2</subject><subject>Tremor</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkcmOEzEQhi0EYsLAKyBLXLj04KXtdl-QUFhmpECQWCROlnFXJ44cO9huEDw9biVEMFyqDvXVX8uPEKbkilHZP3OhQArG72Fw1gW46hRhDaN30ILytm86xsVdtCA9VQ2r4QI9yHlHCFddz-6jC94KSoWUC_TlHUwp-rhx1nj81gQ3Qi6muBgyNmHAqxg2TZ22xx_g2wTeAHYBX8d8cMV49wsG_L7iEErGP1zZ4uX6883LhvYP0b3R-AyPTvkSfXr96uPyulmt39wsX6waKykpDZPjIGwrOyNHy4wRSo3QMqbmvSVwAsJ2fKRUKtlC24EdBjUa1nHS9QCWX6LnR93D9LX-w9ZNkvH6kNzepJ86Gqf_rQS31Zv4XSspZf1mFXh6EkixXpiL3rtswXsTIE5ZM9ExRtsaK_rkFrqL02xEpSQRnAqqSKXUkbIp5pxgPC9DiZ7907f907N_tVRbH_99zLnxj2EVWB-BXXVpA2fApOKsh_-VZR3J5ngacSbt1iQNgf8GqQG54A</recordid><startdate>20211115</startdate><enddate>20211115</enddate><creator>Ishiyama, Hiroyuki</creator><creator>Ishii, Junko</creator><creator>Yoshimura, Hajime</creator><creator>Tsunogae, Marie</creator><creator>Fujiwara, Satoru</creator><creator>Hiya, Satomi</creator><creator>Inui, Ryoma</creator><creator>Shiomi, Yuma</creator><creator>Nakazawa, Shinsaku</creator><creator>Kimura, Masamune</creator><creator>Kuroda, Takehito</creator><creator>Murakami, Yasutaka</creator><creator>Maekawa, Kota</creator><creator>Ohara, Nobuyuki</creator><creator>Kohara, Nobuo</creator><creator>Kawamoto, Michi</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20211115</creationdate><title>Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19</title><author>Ishiyama, Hiroyuki ; Ishii, Junko ; Yoshimura, Hajime ; Tsunogae, Marie ; Fujiwara, Satoru ; Hiya, Satomi ; Inui, Ryoma ; Shiomi, Yuma ; Nakazawa, Shinsaku ; Kimura, Masamune ; Kuroda, Takehito ; Murakami, Yasutaka ; Maekawa, Kota ; Ohara, Nobuyuki ; Kohara, Nobuo ; Kawamoto, Michi</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-26fd5c467a6fc2aa588fe422829186e30e5c73f116864e47ecdd8fa273079eec3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Cerebrovascular diseases</topic><topic>Consciousness</topic><topic>Coronaviruses</topic><topic>COVID-19</topic><topic>Encephalopathy</topic><topic>Female</topic><topic>Hospitalization</topic><topic>Humans</topic><topic>infectious diseases</topic><topic>intensive and critical care</topic><topic>Internal medicine</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Nervous System Diseases - epidemiology</topic><topic>Nervous System Diseases - etiology</topic><topic>Neurological complications</topic><topic>neurology</topic><topic>Neuropathy</topic><topic>Original</topic><topic>Retrospective Studies</topic><topic>SARS-CoV-2</topic><topic>Tremor</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ishiyama, Hiroyuki</creatorcontrib><creatorcontrib>Ishii, Junko</creatorcontrib><creatorcontrib>Yoshimura, Hajime</creatorcontrib><creatorcontrib>Tsunogae, Marie</creatorcontrib><creatorcontrib>Fujiwara, Satoru</creatorcontrib><creatorcontrib>Hiya, Satomi</creatorcontrib><creatorcontrib>Inui, Ryoma</creatorcontrib><creatorcontrib>Shiomi, Yuma</creatorcontrib><creatorcontrib>Nakazawa, Shinsaku</creatorcontrib><creatorcontrib>Kimura, Masamune</creatorcontrib><creatorcontrib>Kuroda, Takehito</creatorcontrib><creatorcontrib>Murakami, Yasutaka</creatorcontrib><creatorcontrib>Maekawa, Kota</creatorcontrib><creatorcontrib>Ohara, Nobuyuki</creatorcontrib><creatorcontrib>Kohara, Nobuo</creatorcontrib><creatorcontrib>Kawamoto, Michi</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ishiyama, Hiroyuki</au><au>Ishii, Junko</au><au>Yoshimura, Hajime</au><au>Tsunogae, Marie</au><au>Fujiwara, Satoru</au><au>Hiya, Satomi</au><au>Inui, Ryoma</au><au>Shiomi, Yuma</au><au>Nakazawa, Shinsaku</au><au>Kimura, Masamune</au><au>Kuroda, Takehito</au><au>Murakami, Yasutaka</au><au>Maekawa, Kota</au><au>Ohara, Nobuyuki</au><au>Kohara, Nobuo</au><au>Kawamoto, Michi</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2021-11-15</date><risdate>2021</risdate><volume>60</volume><issue>22</issue><spage>3559</spage><epage>3567</epage><pages>3559-3567</pages><artnum>7802-21</artnum><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>Objective Various neurological manifestations have been increasingly reported in coronavirus disease 2019 (COVID-19). We determined the neurological features and long-term sequelae in hospitalized COVID-19 patients. Methods We retrospectively studied 95 consecutive hospitalized patients with COVID-19 between March 1 and May 13, 2020. Acute neurological presentations (within two weeks of the symptom onset of COVID-19) were compared between 60 non-severe and 35 severely infected patients who required high-flow oxygen. In the 12 ventilated patients (the most severe group), we evaluated neurological complications during admission, subacute neurological presentations, and neurological sequelae (51 and 137 days from the onset [median], respectively). Results Of the 95 patients (mean age 53 years old; 40% women), 63% had acute neurological presentations, with an increased prevalence in cases of severe infections (83% vs. 52%, p&lt;0.001). Impaired consciousness and limb weakness were more frequent in severe patients than in non-severe ones (0% vs. 49%; p&lt;0.001, and 0% vs. 54%; p&lt;0.001, respectively). In the most severe group (mean age 72 years old; 42% women), 83% of patients had neurological complications [cerebrovascular disease (17%), encephalopathy (82%), and neuropathy (55%)], and 92% had subacute neurological presentations [impaired consciousness (17%), higher brain dysfunction (82%), limb weakness (75%), and tremor (58%)]. Neurological sequelae were found in 83% of cases, including higher brain dysfunction (73%), limb weakness (50%), and tremor (58%). Conclusions Neurological manifestations are common in COVID-19, with the possibility of long-lasting sequelae.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>34511566</pmid><doi>10.2169/internalmedicine.7802-21</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2021/11/15, Vol.60(22), pp.3559-3567
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8666216
source MEDLINE; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; PubMed Central; PubMed Central Open Access
subjects Aged
Cerebrovascular diseases
Consciousness
Coronaviruses
COVID-19
Encephalopathy
Female
Hospitalization
Humans
infectious diseases
intensive and critical care
Internal medicine
Male
Middle Aged
Nervous System Diseases - epidemiology
Nervous System Diseases - etiology
Neurological complications
neurology
Neuropathy
Original
Retrospective Studies
SARS-CoV-2
Tremor
title Neurological Manifestations and Long-term Sequelae in Hospitalized Patients with COVID-19
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T03%3A22%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neurological%20Manifestations%20and%20Long-term%20Sequelae%20in%20Hospitalized%20Patients%20with%20COVID-19&rft.jtitle=Internal%20Medicine&rft.au=Ishiyama,%20Hiroyuki&rft.date=2021-11-15&rft.volume=60&rft.issue=22&rft.spage=3559&rft.epage=3567&rft.pages=3559-3567&rft.artnum=7802-21&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.7802-21&rft_dat=%3Cproquest_pubme%3E2605315180%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2605315180&rft_id=info:pmid/34511566&rfr_iscdi=true